Average ratio of the concentrations obtained with qPCR, before and after DNase treatment, and with DAO before DNase treatment of the ISP phage stocks. by Saar Van Overfelt (20378458)

Subjects:

Average concentration of the ISP phage stocks obtained with qPCR, before and after DNase treatment, and with the DAO method before the DNase treatment. by Saar Van Overfelt (20378458)

Subjects:

Visualization of DNA in an untreated ISP phage stock by immunogold labelling. by Saar Van Overfelt (20378458)

Subjects:

Experimental set up to determine the impact of DNase treatment of ISP phage stocks with different storage periods (ISP-1, ISP-2 and ISP-3) on the quantification with qPCR and the a... by Saar Van Overfelt (20378458)

Subjects:

Stability differences between condition 1 and other conditions across participants on the non-hemiparetic side (NHP) side. by Hyung Suk Yang (20442438)

Subjects:

Stability differences between condition 1 and other conditions across participants on the hemiparetic (HP) side. by Hyung Suk Yang (20442438)

Subjects:

The catalase enzyme response of <i>A</i>. <i>albopictus</i> larvae decreased (1.5-fold) in response to <i>M</i>. <i>robertsii</i>-derived copper nanoparticles. by Perumal Vivekanandhan (4863484)

Subjects:

The activity of representative Fe-S containing enzymes and mitochondrial membrane potential decreased in <i>ssr1-2</i> mutant, and were restored by <i>sus1</i> or <i>sus2</i>. by Xuanjun Feng (8768193)

Analysis of the significantly different metabolomic features. by Bhuripit Saraphol (20855573)

Subjects:

(a) M-K test of annual average water level in Caspian Sea (unformatted fit (UF) and underidentification bias (UB) is positive and reverse order in the time series respectively; ɑ i... by Zihao Duan (17403792)

Subjects:

Average Heart Rate across pre-interview, interview and post-interview phases for High and Low Clarity and Authority groups: Heart Rate (HR) increases from pre-interview to intervie... by David Vagni (8060432)

Subjects:

(a) Mycelial diameter (mm) determination on PDA plates, (b) Inhibition diameters, and (c) inhibition percentages of <i>Aspergillus flavus</i> treated with <i>U. epigea</i> extract... by Martha Cebile Jobe (21175426)

Subjects:

Qualitative analyses of <i>U. epigea</i> bulb phytochemicals. by Martha Cebile Jobe (21175426)

Subjects:

Nucleotide sequence alignment of aflatoxin genes <i>Nor, Omt</i>, <i>Ver</i> and <i>aflR</i> treated with <i>U. epigea</i> extract, Ag/ZnO (Biosynthesized and Conventional) nanopar... by Martha Cebile Jobe (21175426)

Subjects:

<i>Aspergillus flavus</i> mRNA expression (a) <i>aflD</i> and (c) <i>aflR</i> and phylogenetic analysis of (b) <i>aflD</i> and (d) <i>aflR</i> after exposure to 50 mg/mL of <i>U. e... by Martha Cebile Jobe (21175426)

Subjects:

Primer pairs and PCR conditions used for amplification of selected Aflatoxin PCR gene primer pairs and their condition. by Martha Cebile Jobe (21175426)

Subjects:

Availability of modern family planning methods in 2014 and 2017. by Rajon Banik (12066099)

Subjects:

Facilities offering modern family planning services by division in 2014 (A) and 2017 (B). by Rajon Banik (12066099)

Subjects:

Facilities offering modern family planning services by survey years and facility types, 2014 and 2017. by Rajon Banik (12066099)

Subjects:

Factors associated with facility readiness for providing modern family planning services in 2014 and 2017. by Rajon Banik (12066099)

Subjects: